Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Epirus Biopharmaceuticals Inc | 30 |
| 2 | Fred Hutchinson Cancer Center | 19 |
| 3 | Puretech Health PLC | 12 |
| 4 | Endo International PLC | 7 |
| 5 | Corza Medical Inc | 5 |
| 6 | University of Pennsylvania | 3 |
| 7 | Agilent Technologies Inc | 2 |
| 8 | Organon and Co | 2 |
| 9 | Bayer AG | 1 |
| 10 | Coherent Corp | 1 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 61 |
| 2 | A61P | Therapeutic activity (drug indications) | 46 |
| 3 | A01N | Preservation of bodies; biocides; pest repellents | 17 |
| 4 | C12N | Microorganisms, enzymes | 14 |
| 5 | A61M | Devices for introducing media into the body | 11 |
| 6 | Y02A | Climate change adaptation | 7 |
| 7 | A61B | 6 | |
| 8 | A61Q | Cosmetics, personal care | 6 |
| 9 | A61F | 5 | |
| 10 | A61L | Sterilising / disinfecting materials | 5 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| COMBINATORIAL ANALYSIS AND REPAIR | 2010 | Agilent Technologies Inc | 143 |
| Controlled release insufflation carrier for medicaments | 1998 | Endo International PLC | 234 |
| Controlled release insufflation carrier for medicaments | 1997 | Endo International PLC | 229 |
| COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES | 2008 | Excrx Singapore Pte Ltd | 112 |
| METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | 2008 | Epirus Biopharmaceuticals Inc | 93 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2023 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | John C. Ullery | The Ohio State University | 1 |
| 2 | R R LAMB | 1 | |
| 3 | Goldfeder Ac | 1 | |
| 4 | Albert Elmsjö | Swedish National Board of Forensic Medicine | 1 |
| 5 | Robert Kronstrand | Swedish National Board of Forensic Medicine | 1 |
| 6 | Yusuf Ziya Yuceoglu | Maimonides Medical Center | 1 |
| 7 | Ole Christian Lingjærde | 1 | |
| 8 | D. Mario del Pino | St Albans City Hospital | 1 |
| 9 | Calle Bengtsson | Primary HealthCare | 1 |
| 10 | Charles E. Powe | 1 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Prescription of potentially inappropriate medications among older people with intellectual disability: a register study | 2017 | 42 | Heart Failure Treatment and Management |
| Propiomazine Hydrochloride in Obstetrical Analgesia | 1962 | 21 | Anesthesia and Pain Management |
| Effect of organic modifiers on retention and enantiomeric separations by capillary electrophoresis with human serum albumin as a chiral selector in solution | 1997 | 19 | Microfluidic and Capillary Electrophoresis Applications |
| Use of short-acting and long-acting hypnotics and the risk of fracture: a critical analysis of associations in a nationwide cohort | 2019 | 9 | Schizophrenia research and treatment |
| Maternal-fetal effects of propiomazine-meperidine analgesia | 1962 | 8 | Anesthesia and Pain Management |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Propiomazine Hydrochloride?
Which organizations hold the most patents related to Propiomazine Hydrochloride?
What are the main clinical applications discussed in the scientific literature on this compound?
What is the current research activity level for Propiomazine Hydrochloride?
Which patent classifications are most commonly associated with Propiomazine Hydrochloride patents?